<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37919735</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Elevated phospholipids and acylcarnitines C4 and C5 in cerebrospinal fluid distinguish viral CNS infections from autoimmune neuroinflammation.</ArticleTitle><Pagination><StartPage>776</StartPage><MedlinePgn>776</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">776</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-023-04637-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Viral and autoimmune encephalitis may present with similar symptoms, but require different treatments. Thus, there is a need for biomarkers to improve diagnosis and understanding of pathogenesis. We hypothesized that virus-host cell interactions lead to different changes in central nervous system (CNS) metabolism than autoimmune processes and searched for metabolite biomarkers in cerebrospinal fluid (CSF) to distinguish between the two conditions.</AbstractText><AbstractText Label="METHODS">We applied a targeted metabolomic/lipidomic analysis to CSF samples from patients with viral CNS infections (n = 34; due to herpes simplex virus [n = 9], varicella zoster virus [n = 15], enteroviruses [n = 10]), autoimmune neuroinflammation (n = 25; autoimmune anti-NMDA-receptor encephalitis [n = 8], multiple sclerosis [n = 17), and non-inflamed controls (n = 31; Gilles de la Tourette syndrome [n = 20], Bell's palsy with normal CSF cell count [n = 11]). 85 metabolites passed quality screening and were evaluated as biomarkers. Standard diagnostic CSF parameters were assessed for comparison.</AbstractText><AbstractText Label="RESULTS">Of the standard CSF parameters, the best biomarkers were: CSF cell count for viral infections vs. controls (area under the ROC curve, AUC = 0.93), Q-albumin for viral infections vs. autoimmune neuroinflammation (AUC = 0.86), and IgG index for autoimmune neuroinflammation vs. controls (AUC = 0.90). Concentrations of 2 metabolites differed significantly (p &lt; 0.05) between autoimmune neuroinflammation and controls, with proline being the best biomarker (AUC = 0.77). In contrast, concentrations of 67 metabolites were significantly higher in viral infections than controls, with SM.C16.0 being the best biomarker (AUC = 0.94). Concentrations of 68 metabolites were significantly higher in viral infections than in autoimmune neuroinflammation, and the 10 most accurate metabolite biomarkers (AUC = 0.89-0.93) were substantially better than Q-albumin (AUC = 0.86). These biomarkers comprised six phosphatidylcholines (AUC = 0.89-0.92), two sphingomyelins (AUC = 0.89, 0.91), and acylcarnitines isobutyrylcarnitine (C4, AUC = 0.92) and isovalerylcarnitine (C5, AUC = 0.93). Elevated C4 and C5 concentrations suggested dysfunctional mitochondrial β-oxidation and correlated only moderately with CSF cell count (Spearman ρ = 0.41 and 0.44), indicating that their increase is not primarily driven by inflammation.</AbstractText><AbstractText Label="CONCLUSIONS">Changes in CNS metabolism differ substantially between viral CNS infections and autoimmune neuroinflammation and reveal CSF metabolites as pathophysiologically relevant diagnostic biomarkers for the differentiation between the two conditions. In viral CNS infections, the observed higher concentrations of free phospholipids are consistent with disruption of host cell membranes, whereas the elevated short-chain acylcarnitines likely reflect compromised mitochondrial homeostasis and energy generation.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Mekhlafi</LastName><ForeName>Amani</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biostatistics, Helmholtz Centre for Infection Research, Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waqas</LastName><ForeName>Fakhar H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krueger</LastName><ForeName>Maike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klawonn</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Biostatistics, Helmholtz Centre for Infection Research, Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akmatov</LastName><ForeName>Manas K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Research Institute of Ambulatory Care, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller-Vahl</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trebst</LastName><ForeName>Corinna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skripuletz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stangel</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Medicine, Novartis Institute for Biomedical Research, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sühs</LastName><ForeName>Kurt-Wolfram</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pessler</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-3434-2311</Identifier><AffiliationInfo><Affiliation>Biostatistics, Helmholtz Centre for Infection Research, Braunschweig, Germany. frank.pessler@helmholtz-hzi.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Feodor-Lynen-Str. 7, 30625, Hannover, Germany. frank.pessler@helmholtz-hzi.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Individualised Infection Medicine, Hannover, Germany. frank.pessler@helmholtz-hzi.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.24321475</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010743">Phospholipids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C116917">acylcarnitine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000418">Albumins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="Y">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010743" MajorTopicYN="N">Phospholipids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="Y">Central Nervous System Viral Diseases</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000418" MajorTopicYN="N">Albumins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Cell membrane</Keyword><Keyword MajorTopicYN="N">Central nervous system</Keyword><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Fatty acid oxidation</Keyword><Keyword MajorTopicYN="N">Glycerophospholipids</Keyword><Keyword MajorTopicYN="N">Herpes simplex virus</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Isobutyrylcarnitine</Keyword><Keyword MajorTopicYN="N">Isovalerylcarnitine</Keyword><Keyword MajorTopicYN="N">Lecithin</Keyword><Keyword MajorTopicYN="N">Lysophosphatidylcholine</Keyword><Keyword MajorTopicYN="N">Meningitis</Keyword><Keyword MajorTopicYN="N">Metabolism</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">Phosphatidylcholine</Keyword><Keyword MajorTopicYN="N">Phospholipid</Keyword><Keyword MajorTopicYN="N">Sphingomyelin</Keyword><Keyword MajorTopicYN="N">Varicella zoster virus</Keyword><Keyword MajorTopicYN="N">n-methyl-D-aspartate receptor</Keyword></KeywordList><CoiStatement>None of the authors have a conflict of interest relating to conduct of the study or publication of the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>0</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37919735</ArticleId><ArticleId IdType="pmc">PMC10621113</ArticleId><ArticleId IdType="doi">10.1186/s12967-023-04637-y</ArticleId><ArticleId IdType="pii">10.1186/s12967-023-04637-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rotbart HA. Viral meningitis. Semin Neurol. 2000;20(3):277–292. doi: 10.1055/s-2000-9427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2000-9427</ArticleId><ArticleId IdType="pubmed">11051293</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyler KL. Acute viral encephalitis. N Engl J Med. 2018;379(6):557–566. doi: 10.1056/NEJMra1708714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1708714</ArticleId><ArticleId IdType="pubmed">30089069</ArticleId></ArticleIdList></Reference><Reference><Citation>Vora NM, Holman RC, Mehal JM, Steiner CA, Blanton J, Sejvar J. Burden of encephalitis-associated hospitalizations in the United States, 1998–2010. Neurology. 2014;82(5):443–451. doi: 10.1212/WNL.0000000000000086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000086</ArticleId><ArticleId IdType="pubmed">24384647</ArticleId></ArticleIdList></Reference><Reference><Citation>John CC, Carabin H, Montano SM, Bangirana P, Zunt JR, Peterson PK. Global research priorities for infections that affect the nervous system. Nature. 2015;527(7578):S178–S186. doi: 10.1038/nature16033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16033</ArticleId><ArticleId IdType="pmc">PMC4697933</ArticleId><ArticleId IdType="pubmed">26580325</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlejewski K, Bukowska-Osko I, Rydzanicz M, Pawelczyk A, Caraballo Cortѐs K, Osuch S, et al. Next-generation sequencing in the diagnosis of viral encephalitis: sensitivity and clinical limitations. Sci Rep. 2020;10(1):16173. doi: 10.1038/s41598-020-73156-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73156-3</ArticleId><ArticleId IdType="pmc">PMC7528011</ArticleId><ArticleId IdType="pubmed">32999423</ArticleId></ArticleIdList></Reference><Reference><Citation>Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bonstrup M, Havemeister S, et al. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report. Neurology. 2013;81(18):1637–1639. doi: 10.1212/WNL.0b013e3182a9f531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a9f531</ArticleId><ArticleId IdType="pmc">PMC3806918</ArticleId><ArticleId IdType="pubmed">24089390</ArticleId></ArticleIdList></Reference><Reference><Citation>Armangue T, Spatola M, Vlagea A, Mattozzi S, Carceles-Cordon M, Martinez-Heras E, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17(9):760–772. doi: 10.1016/S1474-4422(18)30244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30244-8</ArticleId><ArticleId IdType="pmc">PMC6128696</ArticleId><ArticleId IdType="pubmed">30049614</ArticleId></ArticleIdList></Reference><Reference><Citation>Uy CE, Binks S, Irani SR. Autoimmune encephalitis: clinical spectrum and management. Pract Neurol. 2021;21(5):412–423. doi: 10.1136/practneurol-2020-002567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2020-002567</ArticleId><ArticleId IdType="pmc">PMC8461404</ArticleId><ArticleId IdType="pubmed">34108243</ArticleId></ArticleIdList></Reference><Reference><Citation>Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404. doi: 10.1016/S1474-4422(15)00401-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00401-9</ArticleId><ArticleId IdType="pmc">PMC5066574</ArticleId><ArticleId IdType="pubmed">26906964</ArticleId></ArticleIdList></Reference><Reference><Citation>Granillo A, Le Marechal M, Diaz-Arias L, Probasco J, Venkatesan A, Hasbun R. Development and validation of a risk score to differentiate viral and Autoimmune Encephalitis in adults. Clin Infect Dis. 2023;76(3):e1294–e1301. doi: 10.1093/cid/ciac711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac711</ArticleId><ArticleId IdType="pubmed">36053949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannewitz-Makaj K, Wurster U, Jendretzky KF, Gingele S, Suhs KW, Stangel M, et al. Evidence of oligoclonal bands does not exclude non-inflammatory neurological diseases. Diagnostics (Basel). 2020;11(1):37. doi: 10.3390/diagnostics11010037.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11010037</ArticleId><ArticleId IdType="pmc">PMC7824674</ArticleId><ArticleId IdType="pubmed">33379245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothur K, Wienholt L, Brilot F, Dale RC. CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review. Cytokine. 2016;77:227–237. doi: 10.1016/j.cyto.2015.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2015.10.001</ArticleId><ArticleId IdType="pubmed">26463515</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Yang K, Zhang F, Wang J, Shen H, Liu M, et al. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation. Front Immunol. 2022;13:971659. doi: 10.3389/fimmu.2022.971659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.971659</ArticleId><ArticleId IdType="pmc">PMC9643472</ArticleId><ArticleId IdType="pubmed">36389787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M, Suhs KW, Akmatov MK, Klawonn F, Wang J, Skripuletz T, et al. Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation. J Neuroinflammation. 2018;15(1):20. doi: 10.1186/s12974-017-1041-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-017-1041-0</ArticleId><ArticleId IdType="pmc">PMC5773076</ArticleId><ArticleId IdType="pubmed">29343258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratuszny D, Suhs KW, Novoselova N, Kuhn M, Kaever V, Skripuletz T, et al. Identification of cerebrospinal fluid metabolites as biomarkers for enterovirus meningitis. Int J Mol Sci. 2019;20(2):337. doi: 10.3390/ijms20020337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020337</ArticleId><ArticleId IdType="pmc">PMC6359617</ArticleId><ArticleId IdType="pubmed">30650575</ArticleId></ArticleIdList></Reference><Reference><Citation>de Araujo LS, Pessler K, Suhs KW, Novoselova N, Klawonn F, Kuhn M, et al. Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis. J Transl Med. 2020;18(1):9. doi: 10.1186/s12967-019-02179-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02179-w</ArticleId><ArticleId IdType="pmc">PMC6945415</ArticleId><ArticleId IdType="pubmed">31910875</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mekhlafi A, Suhs KW, Schuchardt S, Kuhn M, Muller-Vahl K, Trebst C, et al. Elevated free phosphatidylcholine levels in cerebrospinal fluid distinguish bacterial from viral CNS infections. Cells. 2021;10(5):1115. doi: 10.3390/cells10051115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10051115</ArticleId><ArticleId IdType="pmc">PMC8148106</ArticleId><ArticleId IdType="pubmed">34066349</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhs KW, Novoselova N, Kuhn M, Seegers L, Kaever V, Muller-Vahl K, et al. Kynurenine is a cerebrospinal fluid biomarker for bacterial and viral central nervous system infections. J Infect Dis. 2019;220(1):127–138. doi: 10.1093/infdis/jiz048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz048</ArticleId><ArticleId IdType="pubmed">30721966</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiber H. Cerebrospinal fluid–physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4(3):99–107.</Citation><ArticleIdList><ArticleId IdType="pubmed">9762655</ArticleId></ArticleIdList></Reference><Reference><Citation>Le S, Josse J, Husson F. FactoMineR: a package for multivariate analysis. J Stat Softw. 2008;25:1–18. doi: 10.18637/jss.v025.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v025.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassambra A, Mundt F. factoextra: Extract and Visualize the Results of Multivariate Data Analyses 2020 [Available from: https://rpkgs.datanovia.com/factoextra/index.html]</Citation></Reference><Reference><Citation>Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21(20):3940–3941. doi: 10.1093/bioinformatics/bti623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bti623</ArticleId><ArticleId IdType="pubmed">16096348</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006;7:91. doi: 10.1186/1471-2105-7-91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-7-91</ArticleId><ArticleId IdType="pmc">PMC1397873</ArticleId><ArticleId IdType="pubmed">16504092</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymanska E, Saccenti E, Smilde AK, Westerhuis JA. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics. 2012;8(1):3–16. doi: 10.1007/s11306-011-0330-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-011-0330-3</ArticleId><ArticleId IdType="pmc">PMC3337399</ArticleId><ArticleId IdType="pubmed">22593721</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mekhlafi A, Becker T, Klawonn F. Sample size and performance estimation for biomarker combinations based on pilot studies with small sample sizes. Commun Stat Theor. 2020 doi: 10.1080/03610926.2020.1843053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03610926.2020.1843053</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Ratón M, Rodríguez-Álvarez MX, Cadarso-Suárez C, Gude-Sampedro F. OptimalCutpoints: an R package for selecting optimal cutpoints in diagnostic tests. J Stat Softw. 2014;61:1–36. doi: 10.18637/jss.v061.i08.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v061.i08</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed: Wiley Interscience; 2000.</Citation></Reference><Reference><Citation>Adeva-Andany MM, Carneiro-Freire N, Seco-Filgueira M, Fernandez-Fernandez C, Mourino-Bayolo D. Mitochondrial beta-oxidation of saturated fatty acids in humans. Mitochondrion. 2019;46:73–90. doi: 10.1016/j.mito.2018.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2018.02.009</ArticleId><ArticleId IdType="pubmed">29551309</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry N, Suspene R, Caval V, Khalfi P, Beauclair G, Rigaud S, et al. Herpes simplex virus type 1 infection disturbs the mitochondrial network, leading to type i interferon production through the RNA polymerase III/RIG-I pathway. mBio. 2021;12(6):e0255721. doi: 10.1128/mBio.02557-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02557-21</ArticleId><ArticleId IdType="pmc">PMC8609356</ArticleId><ArticleId IdType="pubmed">34809467</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller AC, Badani H, McClatchey PM, Baird NL, Bowlin JL, Bouchard R, et al. Varicella zoster virus infection of human fetal lung cells alters mitochondrial morphology. J Neurovirol. 2016;22(5):674–682. doi: 10.1007/s13365-016-0457-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-016-0457-0</ArticleId><ArticleId IdType="pmc">PMC5480379</ArticleId><ArticleId IdType="pubmed">27245593</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik MNH, Waqas SF, Zeitvogel J, Cheng J, Geffers R, Gouda ZA, et al. Congenital deficiency reveals critical role of ISG15 in skin homeostasis. J Clin Invest. 2022 doi: 10.1172/JCI141573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI141573</ArticleId><ArticleId IdType="pmc">PMC8803340</ArticleId><ArticleId IdType="pubmed">34847081</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas SF, Sohail A, Nguyen AHH, Usman A, Ludwig T, Wegner A, et al. ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives. Clin Transl Med. 2022;12(7):e931. doi: 10.1002/ctm2.931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.931</ArticleId><ArticleId IdType="pmc">PMC9288839</ArticleId><ArticleId IdType="pubmed">35842904</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, Mohn N, Skripuletz T, Senel M, Tumani H, Pessler F, et al. Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway. Ann Clin Transl Neurol. 2021;8(12):2228–2234. doi: 10.1002/acn3.51383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51383</ArticleId><ArticleId IdType="pmc">PMC8670317</ArticleId><ArticleId IdType="pubmed">34623755</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Deshmukh P. Bell’s palsy: a review. Cureus. 2022;14(10):e30186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9648613</ArticleId><ArticleId IdType="pubmed">36397921</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>